Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
The following areas of research will be considered in-scope:
a. Societal impact of COVID-19 • Understand the psychological impact, impact on working behaviors, social determinants of health, child development, education, access to healthcare, healthcare resource utilization, direct and indirect costs and impact on QoL
b. Key populations at high-risk of severe COVID-19 outcomes • Further understand impact of COVID-19 in high-risk population groups, especially in immunocompromised and elderly patients and in patients with multiple co-morbidities.
c. Long term outcomes of COVID-19 • Studies assessing long-term or secondary consequences of the disease, including impact of reinfection and effects of different variants (includes but not exclusive to Long COVID/ post-acute sequelae of SARS CoV-2 infection (PASC))
d. Treatment of mild-to-moderate COVID-19 in vaccinated and or seropositive patients with nirmatrelvir/ritonavir
e. Impact of treatment for mild-to-moderate COVID-19 with nirmatrelvir/ritonavir on viral load, infectivity and/or transmission and/or viral rebound and/or symptom resolution
f. Regarding use of nirmatrelvir/ritonavir and showing outcomes: prescription behaviors (reason for non-prescription), patient refusal reasons, access and adherence to treatment
Applicants are encouraged to collaborate across departments where appropriate (e.g. education, social services, health etc) and there will be interest in seeing multi-country applications to allow for comparisons between countries on certain areas of interest.
Letter of Intent (LOI) due date: November 17, 2022
Geographic Scope • Global
To be eligible: • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, Psychology or Social Work. • Applicant must be affiliated with a host institution
Individual projects requesting up to $200,000 USD will be considered. Pfizer anticipates awarding up to 5 grants.